With respect to this, a major link may be represented by PREX1 (RAC-exchanger-factor-1), an important determinant of the sensitivity of breast cancer cells to PI3K inhibitors (Ebi et al, 2013). The gene discussed is PREX1; the disease is breast carcinoma.